Literature DB >> 14048158

ACUTE TRANSVERSE MYELOPATHY.

P H ALTROCCHI.   

Abstract

Keywords:  CENTRAL NERVOUS SYSTEM DISEASES; INFANT; NEUROLOGIC MANIFESTATIONS; SPINAL CORD; STATISTICS

Mesh：

Year:  1963        PMID： 14048158     DOI： 10.1001/archneur.1963.00460080021002

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  14 in total

Review 1.  A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis.

Authors:  Christopher Eckstein; Shiv Saidha; Michael Levy
Journal:  J Neurol       Date:  2011-09-20       Impact factor: 4.849

2.  Subacute myelopathy caused by spinal venous infarction.

Authors:  C E Clarke; W J Cumming
Journal:  Postgrad Med J       Date:  1987-08       Impact factor: 2.401

3.  Acute transverse myelitis as a complication of glandular fever.

Authors:  P B Cotton; M M Webb-Peploe
Journal:  Br Med J       Date:  1966-03-12

4.  Orthopaedic aspects of drug addiction.

Authors:  R L Anderson
Journal:  J Natl Med Assoc       Date:  1974-03       Impact factor: 1.798

5.  Syphilitic myelopathy.

Authors:  M H Silber
Journal:  Genitourin Med       Date:  1989-10

6.  MRI in acute transverse myelopathy.

Authors:  S Holtås; N Basibüyük; K Fredriksson
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

7.  Neurological complications of so-called "influenza". A winter study in South-east Wales.

Authors:  C E Wells
Journal:  Br Med J       Date:  1971-02-13

8.  Recurrent transverse myelitis associated with collagen disease.

Authors:  M Yamamoto
Journal:  J Neurol       Date:  1986-06       Impact factor: 4.849

9.  Post-COVID-19 Acute Transverse Myelitis: A Case Report and Literature Review.

Authors:  Rija Qazi; Ayesha Memon; Alaa S Mohamed; Muneeba Ali; Romil Singh
Journal:  Cureus       Date:  2021-12-22

Review 10.  Demyelinating disorders: update on transverse myelitis.

Authors:  Chitra Krishnan; Adam I Kaplin; Carlos A Pardo; Douglas A Kerr; Sanjay C Keswani
Journal:  Curr Neurol Neurosci Rep       Date:  2006-05       Impact factor: 6.030
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.